Interestingly, the combinations of NPM1 mutations with IDH2R172 for all AML patients and the mutational combinations NPM1/TP53, NPM1/RUNX1 and NPM1/ASXL1 for elderly patients are mutually exclusive [19]. Here, TP53 is linked to acute myeloid leukemia.